Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001831215-26-000002

CHIEF BUSINESS OFFICER sold 1,092 shares at $25.00 ($27,300)

  • CHIEF BUSINESS OFFICER acquired 1,092 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Horn Kinney CHIEF BUSINESS OFFICER 2026-07-07 Option exercise 10b5-1 +1,092 $12.92 $14,109 1,092 D: show line 1 in the form
Horn Kinney CHIEF BUSINESS OFFICER 2026-07-07 Sale 10b5-1 −1,092 $25.00 $27,300 0 D: show line 2 in the form
Open-market sales · 1,092 sh · avg $25.00 · $27,300

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Horn Kinney CHIEF BUSINESS OFFICER 2026-07-07 Option exercise · Employee Stock Option (right to buy) 10b5-1 −1,092 128,908 D: show line 3 in the form
Loading xslF345X06/form4-07092026_090734.xml…